GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unjha Formulations Ltd (BOM:531762) » Definitions » Net Margin %

Unjha Formulations (BOM:531762) Net Margin % : 5.95% (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Unjha Formulations Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Unjha Formulations's Net Income for the three months ended in Dec. 2024 was ₹2.2 Mil. Unjha Formulations's Revenue for the three months ended in Dec. 2024 was ₹37.6 Mil. Therefore, Unjha Formulations's net margin for the quarter that ended in Dec. 2024 was 5.95%.

The historical rank and industry rank for Unjha Formulations's Net Margin % or its related term are showing as below:

BOM:531762' s Net Margin % Range Over the Past 10 Years
Min: 1.04   Med: 2.24   Max: 4
Current: 4


BOM:531762's Net Margin % is ranked worse than
51.89% of 977 companies
in the Drug Manufacturers industry
Industry Median: 4.56 vs BOM:531762: 4.00

Unjha Formulations Net Margin % Historical Data

The historical data trend for Unjha Formulations's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unjha Formulations Net Margin % Chart

Unjha Formulations Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.91 1.04 1.78 2.15 1.50

Unjha Formulations Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 -3.95 17.68 -2.92 5.95

Competitive Comparison of Unjha Formulations's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Unjha Formulations's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Unjha Formulations's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Unjha Formulations's Net Margin % distribution charts can be found below:

* The bar in red indicates where Unjha Formulations's Net Margin % falls into.


;
;

Unjha Formulations Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Unjha Formulations's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=2.779/184.96
=1.50 %

Unjha Formulations's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=2.24/37.624
=5.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Unjha Formulations  (BOM:531762) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Unjha Formulations Net Margin % Related Terms

Thank you for viewing the detailed overview of Unjha Formulations's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Unjha Formulations Business Description

Traded in Other Exchanges
N/A
Address
Khali Char Rasta, State Highway, Sidhpur, Khali, Patan, GJ, IND, 384151
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.

Unjha Formulations Headlines

No Headlines